Peptide Vial Math

How many units is 2.5 mg of Tirzepatide?

2.5 mg of Tirzepatide is 50 units on a U-100 syringe at 5 mg/mL (10 mg + 2 mL): 2.5 ÷ 5 = 0.5 mL, and 1 mL = 100 units.

A different vial or water volume gives a different reading, so use the chart. Confusing units with mL has caused tenfold errors, as the FDA has documented.

By Peptide Vial Math Editorial Team Reviewed by the team on (how we review) Updated Formulas unit-tested (methodology)

Tirzepatide reconstitution calculator

Vial mg, water mL and amount give syringe units

mg

Total printed on the vial label.

mL

Diluent volume you add (1 mL = 100 units on a U-100 syringe).

Amount unit

The mass you want in one draw. 1 mg = 1,000 mcg.

Syringe barrel
Show U-40 and U-50 syringes

Result

50units

to draw on a U-100 syringe, 100-unit barrel

Vial: 10 mg with 2 mL diluent 10 mg +2 mL
Syringe filled to 50.0 of 100 units 0 10 20 30 40 50 60 70 80 90 100 U-100, 1 mL
Volume
0.5 mL
Concentration
5 mg/mL
Per unit
50 mcg
Draws per vial
4

10 mg + 2 mL = 5 mg/mL, so 2.5 mg is 0.5 mL, or 50 units on a U-100 syringe.

Arithmetic only. Not a dosing recommendation. Check every figure against your vial label and lab protocol.

FDA-approved tirzepatide (Zepbound) is supplied premeasured: single-dose pens or vials of 2.5 mg/0.5 mL up to 15 mg/0.5 mL, and a 10 mg/2.4 mL (4.17 mg/mL) multi-dose vial or KwikPen holding four 2.5 mg/0.6 mL doses. Those products follow their own label and instructions, not this arithmetic. (FDA-approved label)

How many units at each concentration?

2.5 mg in U-100 units, by vial size and water added
Vial1 mL water2 mL water3 mL water
5 mg50100150 (> 100)
10 mg255075
15 mg16.733.350
30 mg8.316.725
60 mg4.28.312.5

Readings above 100 units need more than 1 mL and do not fit one 100-unit barrel. "—" means the vial holds less than 2.5 mg.

Worked example

  1. Concentration. 10 mg ÷ 2 mL = 5 mg/mL (0.5 mg per 10 units).
  2. Volume. 2.5 mg ÷ 5 mg/mL = 0.5 mL.
  3. Units. 0.5 mL × 100 = 50 units on U-100 (25 on U-50, 20 on U-40).
  4. Check. 50 units fits a 0.5 mL (50-unit) barrel. 2.5 mg × 1,000 = 2,500 mcg.

Precision matters most at small readings: in a study of nurses measuring low insulin doses, syringe errors were largest at 2 units.

Three unlabeled glass vials on dark slate: one holding white freeze-dried powder, one clear liquid and one empty
Powder, solution, empty vial: the same amount reads differently in different volumes. Generated image made for Peptide Vial Math.

Related: Tirzepatide calculator, mg to units converter, units to mL, how insulin syringes are scaled.

Frequently asked questions

How many units is 2.5 mg of Tirzepatide on a U-100 syringe?

It depends on the concentration. At 5 mg/mL (10 mg + 2 mL) it is 50 units (0.5 mL). From a 5 mg vial in 2 mL it is 100 units; From a 15 mg vial in 2 mL it is 33.3 units.

Why isn't 2.5 mg always the same number of units?

A unit is a volume mark (0.01 mL on U-100), not an amount of substance. The same 2.5 mg takes up more volume in a weaker solution and less in a stronger one, so the reading changes with the vial size and the water added.

How do I work out 2.5 mg in units myself?

Divide the vial mg by the water mL to get mg/mL, divide 2.5 mg by that, then multiply by 100. For 10 mg in 2 mL: 2.5 ÷ 5 × 100 = 50 units.

What if the reading is over 100 units?

Then the amount needs more than 1 mL at that concentration and will not fit one 100-unit barrel. A smaller water volume makes the solution stronger and the reading smaller. Recheck the arithmetic before measuring anything.

Is this a Tirzepatide dose?

No. 2.5 mg is used here only as a number to convert. Peptide Vial Math does arithmetic and never recommends an amount or schedule.

Sources

  1. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products — U.S. Food and Drug Administration, 2024
  2. A Clinical Reminder About the Safe Use of Insulin Vials (Grissinger M.) — P&T (PubMed Central), 2015, PMID 26681898
  3. Analysis of factors affecting the accuracy of low-dose insulin dosage using syringes and vials (Kondo M. et al.) — Diabetology International (PubMed Central), 2024, PMID 39101185
  4. Zepbound (tirzepatide) injection: full prescribing information (revised 08/2026) — Eli Lilly and Company (FDA-approved label), 2026
  5. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration

Links checked 2026-10-19.